
Renal benefit appeared only in patients with albuminuria in a 75,455-person BMJ analysis, while sulfonylureas signaled faster decline without it.
In this clip, Jennifer Bruckart, CPhT, Director of Operations and Compliance at WeCare Pharmacy, explains some of the key regulations included in USP 800 and how the new guidelines will impact compounding pharmacies.
In this clip, Jennifer Bruckart, CPhT, Director of Operations and Compliance at WeCare Pharmacy, explains some of the key regulations included in USP 800 and how the new guidelines will impact compounding pharmacies.






